Close
  • Latest News
  • Artificial Intelligence
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Logo
Logo
  • Latest News
  • Artificial Intelligence
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home Cloud
    • Cloud

    Salesforce Makes Push Into Life Sciences With QuintilesIMS Partnership

    By
    David Needle
    -
    April 24, 2017
    Share
    Facebook
    Twitter
    Linkedin
      health care IT

      A new partnership agreement with Salesforce gives QuintilesIMS the ability to create solutions customized for pharmaceutical and other medical firms. The new offerings are expected to help medical firms develop treatments more efficiently, and more effectively manage clinical trials and patient recruitment.

      The multiyear agreement between Salesforce and QuintilesIMS, a leading life sciences firm with over 50,000 employees, is non-exclusive and global. “We’re thrilled. QuintilesIMS is a giant purveyor of data in the prescription drug and life sciences space, and this agreement is further proof of the validity of the Salesforce platform,” Dr. Joshua Newman, chief medical officer at Salesforce, told eWEEK. “It’s so hard to get new drugs to market; this is a move to make the process swifter and more efficient.”

      QuintilesIMS is initially expected to roll out several different services based on the Salesforce Marketing Cloud.

      “We have been in the technology space for quite some time, and we’ve accumulated about 60 years of knowledge in health care, working with pharmaceutical companies, payers and providers. Getting a new drug to market is a long journey,” said Tal Rosenberg, senior vice president of Global Technology Solutions at QuintilesIMS. “We got to a point in the evolution in our business of asking how to accelerate this process of going from molecule to market, and that’s why we chose Salesforce.”

      QuintilesIMS was formed through the merger of Quintiles Transnational and IMS Health in 2016. The combined firm offers products and services that span the range of clinical to commercial health care solutions.

      Under the partnership agreement with Salesforce, QuintilesIMS will build applications on its platform and license them to customers. “I wouldn’t call it a reseller agreement because they add so much of their IP to the stack,” said Newman.

      The initial services QuintilesIMS will offer are likely to be in the area of recruiting patients for clinical trials of new medications. “There is a ton of documentation and paperwork related to consent to participate and whether patients qualify,” said Newman.

      While the Salesforce platform is typically seen as helping the sales process, Newman said many of the same processes apply to health care. “A lot of the marketing assets we offer are going to be of value to life sciences like patient recruitment and being able to measure the effectiveness of marketing and the post clinical trial follow-up,” he said. “These companies are trying to build strong relationships with their clients and deliver great drugs.”

      Salesforce already works closely with industry leaders in health care and other industries such as financial services and retail. But while Salesforce has gained expertise in managing and negotiating these deals, each industry and the companies within have unique requirements.

      “Do we have a template for how to do this? Yes and no,” said Newman. “Yes in the sense that we have agreements with many pharmaceutical companies and others so we know how to do these kinds of deals. Companies choose Salesforce because they see it’s a platform that’s working elsewhere. But no in the sense that every single organization is different; you can’t take a cookie cutter approach. It would be nice if we could just stamp these out, but you can’t, it’s complicated.”

      Analyst R “Ray” Wang said health care companies can benefit from partnering with technology firms and ultimately patients benefit as well.

      “The future of healthcare is at stake in a digital world. Patient success requires co-innovation and co-creation among industry leaders,” said Wang, principal analyst and CEO of Constellation Research, in a statement. “Only with this close level of partnership can true innovation emerge to transform patient outcomes.”

      David Needle
      Based in Silicon Valley, veteran technology reporter David Needle covers mobile, bi g data, and social media among other topics. He was formerly News Editor at Infoworld, Editor of Computer Currents and TabTimes and West Coast Bureau Chief for both InformationWeek and Internet.com.
      Get the Free Newsletter!
      Subscribe to Daily Tech Insider for top news, trends & analysis
      This email address is invalid.
      Get the Free Newsletter!
      Subscribe to Daily Tech Insider for top news, trends & analysis
      This email address is invalid.

      MOST POPULAR ARTICLES

      Latest News

      Zeus Kerravala on Networking: Multicloud, 5G, and...

      James Maguire - December 16, 2022 0
      I spoke with Zeus Kerravala, industry analyst at ZK Research, about the rapid changes in enterprise networking, as tech advances and digital transformation prompt...
      Read more
      Applications

      Datadog President Amit Agarwal on Trends in...

      James Maguire - November 11, 2022 0
      I spoke with Amit Agarwal, President of Datadog, about infrastructure observability, from current trends to key challenges to the future of this rapidly growing...
      Read more
      Cloud

      IGEL CEO Jed Ayres on Edge and...

      James Maguire - June 14, 2022 0
      I spoke with Jed Ayres, CEO of IGEL, about the endpoint sector, and an open source OS for the cloud; we also spoke about...
      Read more
      IT Management

      Intuit’s Nhung Ho on AI for the...

      James Maguire - May 13, 2022 0
      I spoke with Nhung Ho, Vice President of AI at Intuit, about adoption of AI in the small and medium-sized business market, and how...
      Read more
      Applications

      Kyndryl’s Nicolas Sekkaki on Handling AI and...

      James Maguire - November 9, 2022 0
      I spoke with Nicolas Sekkaki, Group Practice Leader for Applications, Data and AI at Kyndryl, about how companies can boost both their AI and...
      Read more
      Logo

      eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site’s focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Advertisers

      Advertise with TechnologyAdvice on eWeek and our other IT-focused platforms.

      Advertise with Us

      Menu

      • About eWeek
      • Subscribe to our Newsletter
      • Latest News

      Our Brands

      • Privacy Policy
      • Terms
      • About
      • Contact
      • Advertise
      • Sitemap
      • California – Do Not Sell My Information

      Property of TechnologyAdvice.
      © 2022 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×